Page last updated: 2024-09-05

tesaglitazar and glucagon-like peptide 1

tesaglitazar has been researched along with glucagon-like peptide 1 in 1 studies

Compound Research Comparison

Studies
(tesaglitazar)
Trials
(tesaglitazar)
Recent Studies (post-2010)
(tesaglitazar)
Studies
(glucagon-like peptide 1)
Trials
(glucagon-like peptide 1)
Recent Studies (post-2010) (glucagon-like peptide 1)
7413259,4841,2086,374

Protein Interaction Comparison

ProteinTaxonomytesaglitazar (IC50)glucagon-like peptide 1 (IC50)
Glucagon-like peptide 1 receptorHomo sapiens (human)0.0051

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Bakhti, M; Bastidas-Ponce, A; Baugé, E; Campbell, JE; Capozzi, M; Clemmensen, C; Collden, G; Cota, P; DiMarchi, RD; Douros, J; Drucker, DJ; DuBois, B; Feuchtinger, A; Finan, B; Garcia-Caceres, C; Grandl, G; Harger, A; Hennuyer, N; Herzig, S; Hofmann, SM; Klingelhuber, F; Knerr, PJ; Krahmer, N; Kulaj, K; Lalloyer, F; Lickert, H; Liskiewicz, A; Liskiewicz, D; Maity, G; Müller, TD; Novikoff, A; Perez-Tilve, D; Prakash, S; Quarta, C; Sanchez-Garrido, MA; Staels, B; Stemmer, K; Tschöp, MH; Yang, B; Zhang, Q1

Other Studies

1 other study(ies) available for tesaglitazar and glucagon-like peptide 1

ArticleYear
GLP-1-mediated delivery of tesaglitazar improves obesity and glucose metabolism in male mice.
    Nature metabolism, 2022, Volume: 4, Issue:8

    Topics: Alkanesulfonates; Animals; Body Weight; Diabetes Mellitus, Type 2; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glucose; Male; Mice; Obesity; Phenylpropionates; PPAR alpha

2022